Illness	Number of cases
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	227
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	181
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	140
Hyperplasia of prostate (N40)	137
Calculus of kidney and ureter - Calculus of ureter (N20.1)	107
Calculus of kidney and ureter - Calculus of kidney (N20.0)	101
Obstructive and reflux uropathy (N13.3)	66
Cystitis (N30.9)	60
Carcinoma in situ of other and unspecified sites - Carcinoma in situ of bladder (D09.0)	55
Malignant neoplasm of prostate (C61)	42

Top 10 treatments

Treatment	Number
Examination of the urethra and the urinary bladder by endoscopy (1-661)	509
Injection or administration of medicines into the urinary bladder (8-132.2)	394
Injection or administration of medicines into the urinary bladder (8-132.3)	346
Measurement of urethral width (1-336)	334
Insertion, exchange or removal of a ureteral stent (8-137.00)	299
Examination of the urinary tract by endoscopy through a surgical incision or during an operation (1-693.2)	289
Insertion, exchange or removal of a ureteral stent (8-137.10)	278
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	265
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	253
Computed tomography of the abdomen with contrast medium (3-225)	233

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
109	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
61	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
61	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB15	Anaesthesia technical assistant (m/f)
HB01	Nurse and health care worker (m/f)
HB19	Nursing professionals
HB17	Auxiliary nurse (m/f)
HB07	Surgical technical assistant (m/f)